GlassScriptPhysician profile
Travis Lee Wiggins
NPI 1396239547
$504.87
in general payments reported to CMS, 2019-2025
11 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $83.72 · 2023: $168 · 2024: $77.96 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $421.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $168.12 | 2023 | Seglentis, Livalo |
| Genentech USA, INC. | $83.72 | 2021 | |
| Novo Nordisk INC | $80.46 | 2024-2025 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $30.61 | 2024-2025 | Airsupra |
| Philips North America LLC | $27.00 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Genzyme Corporation | $24.03 | 2025 | |
| Dexcom, INC. | $23.30 | 2024 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $18.49 | 2025 | Trelegy Ellipta |
| Lilly USA, LLC | $18.14 | 2025 | Zepbound |
| Amgen INC. | $17.11 | 2025 | Evenity |
| Exact Sciences Corporation | $13.89 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Wiggins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.